Effects of atorvastatin 10 mg and simvastatin 20 mg on serum triglyceride levels in patients with hypercholesterolemia

Adriana Branchi, Anna Maria Fiorenza, Adriana Torri, Fulvio Muzio, Angelo Rovellini, Cristina Berra, Domenico Sommariva

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: Some reports suggest that atorvastatin is more effective than other statins in decreasing serum triglyceride (TG) levels in patients with hypercholesterolemia. Objective: The aim of this study is to compare the hypotriglyceridemic activity of atorvastatin and simvastatin at doses that elicit similar hypocholesterolemic effects. Methods: Outpatients with primary hypercholesterolemia that was not adequately controlled with a stable low-fat, low-cholesterol diet were randomized to t of 2 treatments: atorvastatin 10 mg daily (n = 100) or simvastatin 20 mg daily (n = 100) for up to 6 months. Serum TG, total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C) levels were measured at baseline and after 2 and 6 months of therapy. Results: After 2 months of therapy, serum TG, TC, and LDL-C levels significantly decreased (P <0.001) and HDL-C levels significantly increased (P <0.01) in both treatment groups compared with baseline values. The percentage changes in serum TG, TC, and LDL-C levels were similar, whereas the percentage increase in HDL-C level was greater in the simvastatin group than in the atorvastatin group. In both groups of patients, the decrease in serum TG level was correlated with baseline serum TG levels; patients with high baseline serum TG levels had a greater hypotriglyceridemic response than patients with low baseline serum TG levels. After adjusting for the error due to regression to the mean, the difference in hypotriglyceridemic response between patients with high and those with low pretreatment serum TG levels decreased in both treatment groups. Conclusions: In patients with hypercholesterolemia, atorvastatin 10 mg/d and simvastatin 20 mg/d had similar effects on serum TG, TC, and LDL-C levels. Both drugs increased HDL-C levels, but the effect of simvastatin was significantly greater than that of atorvastatin.

Original languageEnglish
Pages (from-to)408-415
Number of pages8
JournalCurrent Therapeutic Research
Volume62
Issue number5
DOIs
Publication statusPublished - 2001

Fingerprint

Simvastatin
Hypercholesterolemia
Triglycerides
Serum
LDL Cholesterol
Cholesterol
HDL Cholesterol
Atorvastatin Calcium
Therapeutics
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Fat-Restricted Diet
Outpatients

Keywords

  • Atorvastatin
  • High-density lipoprotein cholesterol
  • Low-density lipoprotein cholesterol
  • Simvastatin
  • Triglycerides

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Effects of atorvastatin 10 mg and simvastatin 20 mg on serum triglyceride levels in patients with hypercholesterolemia. / Branchi, Adriana; Fiorenza, Anna Maria; Torri, Adriana; Muzio, Fulvio; Rovellini, Angelo; Berra, Cristina; Sommariva, Domenico.

In: Current Therapeutic Research, Vol. 62, No. 5, 2001, p. 408-415.

Research output: Contribution to journalArticle

Branchi, Adriana ; Fiorenza, Anna Maria ; Torri, Adriana ; Muzio, Fulvio ; Rovellini, Angelo ; Berra, Cristina ; Sommariva, Domenico. / Effects of atorvastatin 10 mg and simvastatin 20 mg on serum triglyceride levels in patients with hypercholesterolemia. In: Current Therapeutic Research. 2001 ; Vol. 62, No. 5. pp. 408-415.
@article{9633c189d3564a2baf5c06d451b44360,
title = "Effects of atorvastatin 10 mg and simvastatin 20 mg on serum triglyceride levels in patients with hypercholesterolemia",
abstract = "Background: Some reports suggest that atorvastatin is more effective than other statins in decreasing serum triglyceride (TG) levels in patients with hypercholesterolemia. Objective: The aim of this study is to compare the hypotriglyceridemic activity of atorvastatin and simvastatin at doses that elicit similar hypocholesterolemic effects. Methods: Outpatients with primary hypercholesterolemia that was not adequately controlled with a stable low-fat, low-cholesterol diet were randomized to t of 2 treatments: atorvastatin 10 mg daily (n = 100) or simvastatin 20 mg daily (n = 100) for up to 6 months. Serum TG, total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C) levels were measured at baseline and after 2 and 6 months of therapy. Results: After 2 months of therapy, serum TG, TC, and LDL-C levels significantly decreased (P <0.001) and HDL-C levels significantly increased (P <0.01) in both treatment groups compared with baseline values. The percentage changes in serum TG, TC, and LDL-C levels were similar, whereas the percentage increase in HDL-C level was greater in the simvastatin group than in the atorvastatin group. In both groups of patients, the decrease in serum TG level was correlated with baseline serum TG levels; patients with high baseline serum TG levels had a greater hypotriglyceridemic response than patients with low baseline serum TG levels. After adjusting for the error due to regression to the mean, the difference in hypotriglyceridemic response between patients with high and those with low pretreatment serum TG levels decreased in both treatment groups. Conclusions: In patients with hypercholesterolemia, atorvastatin 10 mg/d and simvastatin 20 mg/d had similar effects on serum TG, TC, and LDL-C levels. Both drugs increased HDL-C levels, but the effect of simvastatin was significantly greater than that of atorvastatin.",
keywords = "Atorvastatin, High-density lipoprotein cholesterol, Low-density lipoprotein cholesterol, Simvastatin, Triglycerides",
author = "Adriana Branchi and Fiorenza, {Anna Maria} and Adriana Torri and Fulvio Muzio and Angelo Rovellini and Cristina Berra and Domenico Sommariva",
year = "2001",
doi = "10.1016/S0011-393X(01)89005-6",
language = "English",
volume = "62",
pages = "408--415",
journal = "Current Therapeutic Research - Clinical and Experimental",
issn = "0011-393X",
publisher = "Excerpta Medica",
number = "5",

}

TY - JOUR

T1 - Effects of atorvastatin 10 mg and simvastatin 20 mg on serum triglyceride levels in patients with hypercholesterolemia

AU - Branchi, Adriana

AU - Fiorenza, Anna Maria

AU - Torri, Adriana

AU - Muzio, Fulvio

AU - Rovellini, Angelo

AU - Berra, Cristina

AU - Sommariva, Domenico

PY - 2001

Y1 - 2001

N2 - Background: Some reports suggest that atorvastatin is more effective than other statins in decreasing serum triglyceride (TG) levels in patients with hypercholesterolemia. Objective: The aim of this study is to compare the hypotriglyceridemic activity of atorvastatin and simvastatin at doses that elicit similar hypocholesterolemic effects. Methods: Outpatients with primary hypercholesterolemia that was not adequately controlled with a stable low-fat, low-cholesterol diet were randomized to t of 2 treatments: atorvastatin 10 mg daily (n = 100) or simvastatin 20 mg daily (n = 100) for up to 6 months. Serum TG, total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C) levels were measured at baseline and after 2 and 6 months of therapy. Results: After 2 months of therapy, serum TG, TC, and LDL-C levels significantly decreased (P <0.001) and HDL-C levels significantly increased (P <0.01) in both treatment groups compared with baseline values. The percentage changes in serum TG, TC, and LDL-C levels were similar, whereas the percentage increase in HDL-C level was greater in the simvastatin group than in the atorvastatin group. In both groups of patients, the decrease in serum TG level was correlated with baseline serum TG levels; patients with high baseline serum TG levels had a greater hypotriglyceridemic response than patients with low baseline serum TG levels. After adjusting for the error due to regression to the mean, the difference in hypotriglyceridemic response between patients with high and those with low pretreatment serum TG levels decreased in both treatment groups. Conclusions: In patients with hypercholesterolemia, atorvastatin 10 mg/d and simvastatin 20 mg/d had similar effects on serum TG, TC, and LDL-C levels. Both drugs increased HDL-C levels, but the effect of simvastatin was significantly greater than that of atorvastatin.

AB - Background: Some reports suggest that atorvastatin is more effective than other statins in decreasing serum triglyceride (TG) levels in patients with hypercholesterolemia. Objective: The aim of this study is to compare the hypotriglyceridemic activity of atorvastatin and simvastatin at doses that elicit similar hypocholesterolemic effects. Methods: Outpatients with primary hypercholesterolemia that was not adequately controlled with a stable low-fat, low-cholesterol diet were randomized to t of 2 treatments: atorvastatin 10 mg daily (n = 100) or simvastatin 20 mg daily (n = 100) for up to 6 months. Serum TG, total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C) levels were measured at baseline and after 2 and 6 months of therapy. Results: After 2 months of therapy, serum TG, TC, and LDL-C levels significantly decreased (P <0.001) and HDL-C levels significantly increased (P <0.01) in both treatment groups compared with baseline values. The percentage changes in serum TG, TC, and LDL-C levels were similar, whereas the percentage increase in HDL-C level was greater in the simvastatin group than in the atorvastatin group. In both groups of patients, the decrease in serum TG level was correlated with baseline serum TG levels; patients with high baseline serum TG levels had a greater hypotriglyceridemic response than patients with low baseline serum TG levels. After adjusting for the error due to regression to the mean, the difference in hypotriglyceridemic response between patients with high and those with low pretreatment serum TG levels decreased in both treatment groups. Conclusions: In patients with hypercholesterolemia, atorvastatin 10 mg/d and simvastatin 20 mg/d had similar effects on serum TG, TC, and LDL-C levels. Both drugs increased HDL-C levels, but the effect of simvastatin was significantly greater than that of atorvastatin.

KW - Atorvastatin

KW - High-density lipoprotein cholesterol

KW - Low-density lipoprotein cholesterol

KW - Simvastatin

KW - Triglycerides

UR - http://www.scopus.com/inward/record.url?scp=0035013542&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035013542&partnerID=8YFLogxK

U2 - 10.1016/S0011-393X(01)89005-6

DO - 10.1016/S0011-393X(01)89005-6

M3 - Article

AN - SCOPUS:0035013542

VL - 62

SP - 408

EP - 415

JO - Current Therapeutic Research - Clinical and Experimental

JF - Current Therapeutic Research - Clinical and Experimental

SN - 0011-393X

IS - 5

ER -